Search Results - "BASTOW, Barbara"

Efficacy of a nucleoside-sparing regimen of darunavir/ ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262) by TAIWO, Babafemi, LU ZHENG, ERON, Joseph J, GALLIEN, Sebastien, MATINING, Roy M, KURITZKES, Daniel R, WILSON, Cara C, BERZINS, Baiba I, ACOSTA, Edward P, BASTOW, Barbara, KIM, Peter S

“…To explore darunavir/ritonavir (DRV/r) plus raltegravir (RAL) combination therapy in antiretroviral-naive patients. Phase IIb, single-arm, open-label,…”
Get full text

Comparison of illumina and 454 deep sequencing in participants failing raltegravir-based antiretroviral therapy by Li, Jonathan Z, Chapman, Brad, Charlebois, Patrick, Hofmann, Oliver, Weiner, Brian, Porter, Alyssa J, Samuel, Reshmi, Vardhanabhuti, Saran, Zheng, Lu, Eron, Joseph, Taiwo, Babafemi, Zody, Michael C, Henn, Matthew R, Kuritzkes, Daniel R, Hide, Winston, Wilson, Cara C, Berzins, Baiba I, Acosta, Edward P, Bastow, Barbara, Kim, Peter S, Read, Sarah W, Janik, Jennifer, Meres, Debra S, Lederman, Michael M, Mong-Kryspin, Lori, Shaw, Karl E, Zimmerman, Louis G, Leavitt, Randi, De La Rosa, Guy, Jennings, Amy

“…The impact of raltegravir-resistant HIV-1 minority variants (MVs) on raltegravir treatment failure is unknown. Illumina sequencing offers greater throughput…”
Get full text

Baseline natural killer and T cell populations correlation with virologic outcome after regimen simplification to atazanavir/ritonavir alone (ACTG 5201) by McKinnon, John E, Mailliard, Robbie B, Swindells, Susan, Wilkin, Timothy J, Borowski, Luann, Roper, Jillian M, Bastow, Barbara, Kearney, Mary, Wiegand, Ann, Mellors, John W, Rinaldo, Charles R

“…Simplified maintenance therapy with ritonavir-boosted atazanavir (ATV/r) provides an alternative treatment option for HIV-1 infection that spares nucleoside…”
Get full text

Metabolic Effects of Protease Inhibitor-Sparing Antiretroviral Regimens Given as Initial Treatment of HIV-1 Infection (AIDS Clinical Trials Group Study A5095) by Shikuma, Cecilia M, Yang, Yang, Glesby, Marshall J, Meyer, William A, Tashima, Karen T, Ribaudo, Heather J, Webb, Nancy, Bastow, Barbara, Kuritzkes, Daniel R, Gulick, Roy M

“…OBJECTIVE:To assess metabolic changes after initiation of protease inhibitor (PI)-sparing regimens in antiretroviral-naive patients. METHODS:Metabolic changes…”
Get full text

Change in high-sensitivity c-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individuals by Shikuma, Cecilia M, Ribaudo, Heather J, Zheng, Yu, Gulick, Roy M, Meyer, William A, Tashima, Karen T, Bastow, Barbara, Kuritzkes, Daniel R, Glesby, Marshall J

“…Elevations in C-reactive protein (CRP) are associated with increased cardiovascular disease (CVD) risk, increased HIV disease progression, and death in…”
Get more information

Predictive Value of Pharmacokinetics-Adjusted Phenotypic Susceptibility on Response to Ritonavir-Enhanced Protease Inhibitors (PIs) in Human Immunodeficiency Virus-Infected Subjects Failing Prior PI Therapy by ERON, Joseph J, PARK, Jeong-Gun, HAUBRICH, Richard, AWEEKA, Francesca, BASTOW, Barbara, PAKES, Gary E, SONG YU, HULIN WU, RICHMAN, Douglas D

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298 by Wilkin, Timothy J, Chen, Huichao, Cespedes, Michelle S, Leon-Cruz, Jorge T, Godfrey, Catherine, Chiao, Elizabeth Y, Bastow, Barbara, Webster-Cyriaque, Jennifer, Feng, Qinghua, Dragavon, Joan, Coombs, Robert W, Presti, Rachel M, Saah, Alfred, Cranston, Ross D

“…Anal cancer is common in human immunodeficiency virus-infected adults. This randomized trial did not find a benefit from human papillomavirus (HPV) vaccination…”
Get full text

Continued Slow Decay of the Residual Plasma Viremia Level in HIV-1–Infected Adults Receiving Long-term Antiretroviral Therapy by Riddler, Sharon A., Aga, Evgenia, Bosch, Ronald J., Bastow, Barbara, Bedison, Margaret, Vagratian, David, Vaida, Florin, Eron, Joseph J., Gandhi, Rajesh T., Mellors, John W.

“…We measured plasma human immunodeficiency virus type 1 (HIV-1) RNA levels by means of single-copy assay in 334 participants receiving virologically suppressive…”
Get full text

No Risk of Myocardial Infarction Associated With Initial Antiretroviral Treatment Containing Abacavir: Short and Long-Term Results from ACTG A5001/ALLRT by Ribaudo, Heather J., Benson, Constance A., Zheng, Yu, Koletar, Susan L., Collier, Ann C., Lok, Judith J., Smurzynski, Marlene, Bosch, Ronald J., Bastow, Barbara, Schouten, Jeffrey T.

“…Background. Observational and retrospective clinical trial cohorts have reported conflicting results for the association of abacavir use with risk of…”
Get full text

Telmisartan Therapy Does Not Improve Lymph Node or Adipose Tissue Fibrosis More Than Continued Antiretroviral Therapy Alone by Utay, Netanya S, Kitch, Douglas W, Yeh, Eunice, Fichtenbaum, Carl J, Lederman, Michael M, Estes, Jacob D, Deleage, Claire, Magyar, Clara, Nelson, Scott D, Klingman, Karen L, Bastow, Barbara, Luque, Amneris E, McComsey, Grace A, Douek, Daniel C, Currier, Judith S, Lake, Jordan E

“…Lymph node and adipose tissue fibrosis may limit CD4+ T-cell recovery and contribute to comorbidities in treated human immunodeficiency virus (HIV) infection…”
Get full text

High Baseline Anal Human Papillomavirus and Abnormal Anal Cytology in a Phase 3 Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus–Infected Individuals Older Than 26 Years: ACTG 5298 by Cranston, Ross D, Cespedes, Michelle S, Paczuski, Pawel, Yang, Ming, Coombs, Robert W, Dragavon, Joan, Saah, Alfred, Godfrey, Catherine, Webster-Cyriaque, Jennifer Y, Chiao, Elizabeth Y, Bastow, Barbara, Wilkin, Timothy

“…BACKGROUNDThe quadrivalent human papillomavirus (HPV) vaccine (qHPV; types 6, 11, 16, 18) is indicated for men and women aged 9 to 26 years to prevent HPV…”
Get full text

Three- vs Four-Drug Antiretroviral Regimens for the Initial Treatment of HIV-1 Infection: A Randomized Controlled Trial by Gulick, Roy M, Ribaudo, Heather J, Shikuma, Cecilia M, Lalama, Christina, Schackman, Bruce R, Meyer, William A, Acosta, Edward P, Schouten, Jeffrey, Squires, Kathleen E, Pilcher, Christopher D, Murphy, Robert L, Koletar, Susan L, Carlson, Margrit, Reichman, Richard C, Bastow, Barbara, Klingman, Karin L, Kuritzkes, Daniel R, AIDS Clinical Trials Group (ACTG) A5095 Study Team, for the

“…CONTEXT Three-drug antiretroviral regimens are standard of care for initial treatment of human immunodeficiency virus 1 (HIV-1) infection, but a 4-drug regimen…”
Get full text

High Baseline Anal HPV and Abnormal Anal Cytology in a Phase 3 Trial of the Quadrivalent HPV Vaccine in HIV-infected individuals over 26 years old: ACTG 5298 by Cranston, Ross D., Cespedes, Michelle S., Paczuski, Pawel, Yang, Ming, Coombs, Robert W., Dragavon, Joan, Saah, Alfred, Godfrey, Catherine, Webster-Cyriaque, Jennifer Y., Chiao, Elizabeth Y, Bastow, Barbara, Wilkin, Timothy

Get full text

High Baseline Anal HPV and Abnormal Anal Cytology in a Phase 3 Trial of the Quadrivalent HPV Vaccine in HIV-infected individuals over 26 years old: ACTG 5298 by Cranston, Ross D, Cespedes, Michelle S, Paczuski, Pawel, Yang, Ming, Coombs, Robert W, Dragavon, Joan, Saah, Alfred, Godfrey, Catherine, Webster-Cyriaque, Jennifer Y, Chiao, Elizabeth Y, Bastow, Barbara, Wilkin, Timothy

“…BACKGROUNDThe quadrivalent human papillomavirus (HPV) vaccine (qHPV; types 6, 11, 16, 18) is indicated for men and women 9-26 years to prevent HPV associated…”
Get full text

No Evidence for Decay of the Latent Reservoir in HIV-1—Infected Patients Receiving Intensive Enfuvirtide-Containing Antiretroviral Therapy by Gandhi, Rajesh T., Bosch, Ronald J., Aga, Evgenia, Albrecht, Mary, Demeter, Lisa M., Dykes, Carrie, Bastow, Barbara, Para, Michael, Lai, Jun, Siliciano, Robert F., Siliciano, Janet D., Eron, Joseph J.

“…Human immunodeficiency virus type 1 (HIV-1) persists in a latent reservoir of infected resting memory CD4 cells in patients receiving antiretroviral therapy.We…”
Get full text

Experience and Challenges Presented by a Multicenter Crossover Study of Combination Analgesic Therapy for the Treatment of Painful HIV‐Associated Polyneuropathies by Harrison, Taylor, Miyahara, Sachiko, Lee, Anthony, Evans, Scott, Bastow, Barbara, Simpson, David, Gilron, Ian, Dworkin, Robert, Daar, Eric S., Wieclaw, Linda, Clifford, David B.

“…Objective There is limited evidence for efficacy of analgesics as monotherapy for neuropathic pain associated with HIV‐associated polyneuropathies, in spite of…”
Get full text

Regimen Simplification to Atazanavir-Ritonavir Alone as Maintenance Antiretroviral Therapy: Final 48-Week Clinical and Virologic Outcomes by Wilkin, Timothy J., McKinnon, John E., DiRienzo, A. Gregory, Mollan, Katie, Fletcher, Courtney V., Margolis, David M., Bastow, Barbara, Thal, Gary, Woodward, William, Godfrey, Catherine, Wiegand, Ann, Maldarelli, Frank, Palmer, Sarah, Coffin, John M., Mellors, John W., Swindells, Susan

“…BackgroundSimplified maintenance therapy with ritonavir-boosted atazanavir (ATV/RTV) alone is attractive because of nucleoside reverse-transcriptase inhibitor…”
Get full text

Regimen Simplification to Atazanavir-Ritonavir Alone as Maintenance Antiretroviral Therapy After Sustained Virologic Suppression by Swindells, Susan, DiRienzo, A. Gregory, Wilkin, Timothy, Fletcher, Courtney V, Margolis, David M, Thal, Gary D, Godfrey, Catherine, Bastow, Barbara, Ray, M. Graham, Wang, Hongying, Coombs, Robert W, McKinnon, John, Mellors, John W, AIDS Clinical Trials Group 5201 Study Team, for the

“…CONTEXT The long-term adverse effects, expense, and difficulty of adherence to antiretroviral regimens have led to studies of simpler maintenance therapies…”
Get full text

Residual plasma viraemia and infectious HIV-1 recovery from resting memory CD4 cells in patients on antiretroviral therapy: results from ACTG A5173 by Gandhi, Rajesh T, Bosch, Ronald J, Aga, Evgenia, Bedison, Margaret A, Bastow, Barbara, Schmitz, John L, Siliciano, Janet D, Siliciano, Robert F, Eron, Joseph J, Mellors, John W

“…In HIV-1-infected patients receiving antiretroviral therapy (ART), the relationship between residual viraemia and ex vivo recovery of infectious virus from…”
Get more information

Baseline Natural Killer and T Cell Populations Correlation with Virologic Outcome after Regimen Simplification to Atazanavir/Ritonavir Alone (ACTG 5201): e95524 by McKinnon, John E, Mailliard, Robbie B, Swindells, Susan, Wilkin, Timothy J, Borowski, LuAnn, Roper, Jillian M, Bastow, Barbara, Kearney, Mary, Wiegand, Ann, Mellors, John W

“…Objectives Simplified maintenance therapy with ritonavir-boosted atazanavir (ATV/r) provides an alternative treatment option for HIV-1 infection that spares…”
Get full text